UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 736

Sortiert nach

Heart rate effects of antimuscarinic drugs

International urology and nephrology, 2019-10, Vol.51 (10), p.1783-1784

Haverkamp, W.

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart

European journal of endocrinology, 2019-07, Vol.181 (1), p.79

2019

Link zum Volltext

Verfügbarkeit prüfen

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

Leukemia, 2013-06, Vol.27 (6), p.1316-1321

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure

Heart failure reviews, 2018, Vol.23 (1), p.27-36

2018

Link zum Volltext

Verfügbarkeit prüfen

Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures

Acta neurologica Scandinavica, 2015-11, Vol.132 (5), p.355-363

2015

Link zum Volltext

Verfügbarkeit prüfen

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

European heart journal, 2000-08, Vol.21 (15), p.1216-1231

2000

Link zum Volltext

Verfügbarkeit prüfen

Impact of the β1-Adrenoceptor Arg389Gly Polymorphism on Heart-Rate Responses to Bisoprolol and Carvedilol in Heart-Failure Patients

Clinical pharmacology and therapeutics, 2012-07, Vol.92 (1), p.21-28

2012

Link zum Volltext

Verfügbarkeit prüfen

Potential Cost-Effectiveness Of Therapeutic Drug Monitoring In Patients With Resistant Hypertension

Value in health, 2014-11, Vol.17 (7), p.A486-A486

2014

Link zum Volltext

Verfügbarkeit prüfen

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

The Journal of pharmacology and experimental therapeutics, 2002-10, Vol.303 (1), p.218

2002

Link zum Volltext

Verfügbarkeit prüfen

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Cardiovascular research, 2000-08, Vol.47 (2), p.219-233

2000

Link zum Volltext

Verfügbarkeit prüfen

What physicians do in case of a failure of the pace-sense part of a defibrillation lead: Survey in Germany, Austria and Switzerland

Herz, 2020-06, Vol.45 (4), p.362-368

2020

Link zum Volltext

Verfügbarkeit prüfen

Endomyocardial biopsy in Anderson–Fabry disease: The key in uncertain cases

International journal of cardiology, 2015-07, Vol.190, p.284-286

2015

Link zum Volltext

Verfügbarkeit prüfen

Großer Hype um ChatGPT in der Medizin: Ist es etwas für den Rhythmologen? Was muss man bedenken?

Herzschrittmachertherapie & Elektrophysiologie, 2023-09, Vol.34 (3), p.240-245

2023

Link zum Volltext

Verfügbarkeit prüfen

Dilated Cardiomyopathy in Mice Deficient for the Lysosomal Cysteine Peptidase Cathepsin L

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6234-6239

2002

Link zum Volltext

Verfügbarkeit prüfen

New implantable cardiac monitor with three-lead ECG and active noise detection

Herz, 2017-09, Vol.42 (6), p.585-592

2017

Link zum Volltext

Verfügbarkeit prüfen

Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation

The Journal of pharmacology and experimental therapeutics, 2002-01, Vol.300 (1), p.64

2002

Link zum Volltext

Verfügbarkeit prüfen

Improvement of lay rescuer chest compressions with a novel audiovisual feedback device: A randomized trial

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2018-03, Vol.113 (2), p.124-130

2018

Link zum Volltext

Verfügbarkeit prüfen

EFFECT OF DIFFERENT CUT POINTS FOR DEFINING SUCCESS POST-CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION - A SUB-STUDY OF THE STAR AF II TRIAL

Canadian journal of cardiology, 2016-10, Vol.32 (10), p.S285-S285

2016

Link zum Volltext

Verfügbarkeit prüfen

International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug‐induced torsades de pointes

British journal of pharmacology, 2008-08, Vol.154 (7), p.1491-1501

2008

Link zum Volltext

Verfügbarkeit prüfen

Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome

Neurology, 2002-08, Vol.59 (3), p.466

2002

Link zum Volltext

Verfügbarkeit prüfen

Atypical antipsychotics: From potassium channels to torsade de pointes and sudden death

Drug safety, 2005, Vol.28 (1), p.35-51

2005

Link zum Volltext

Verfügbarkeit prüfen

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3

Basic research in cardiology, 2005-07, Vol.100 (4), p.365-371

2005

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging and implantable cardiac devices. Current status and future perspectives of MR-compatible systems

Herz, 2012-03, Vol.37 (2), p.136-145

2012

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options

Deutsche medizinische Wochenschrift (1946), 2008-11, Vol.133 (45), p.2349

2008

Link zum Volltext

Verfügbarkeit prüfen

Klinische Besonderheiten der Therapie mit Amiodaron

Herzschrittmachertherapie & Elektrophysiologie, 2017-09, Vol.28 (3), p.307-316

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 736

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(637)
Mit Volltextzugriff
(644)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(433)
Life Sciences & Biomedicine
(380)
Humans
(317)
Male
(181)
Female
(178)
Cardiovascular System & Cardiology
(133)
Cardiac & Cardiovascular Systems
(129)
Biological And Medical Sciences
(127)
Middle Aged
(116)
Adult
(113)
Animals
(108)
Medical Sciences
(96)
Aged
(91)
Electrocardiography
(67)
Technology
(64)
Physical Sciences
(54)
Adolescent
(47)
Heart
(46)
Risk Factors
(43)
Cardiology. Vascular System
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Heart rate effects of antimuscarinic drugs

Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure

Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Impact of the β1-Adrenoceptor Arg389Gly Polymorphism on Heart-Rate Responses to Bisoprolol and Carvedilol in Heart-Failure Patients

Potential Cost-Effectiveness Of Therapeutic Drug Monitoring In Patients With Resistant Hypertension

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

What physicians do in case of a failure of the pace-sense part of a defibrillation lead: Survey in Germany, Austria and Switzerland

Endomyocardial biopsy in Anderson–Fabry disease: The key in uncertain cases

Großer Hype um ChatGPT in der Medizin: Ist es etwas für den Rhythmologen? Was muss man bedenken?

Dilated Cardiomyopathy in Mice Deficient for the Lysosomal Cysteine Peptidase Cathepsin L

New implantable cardiac monitor with three-lead ECG and active noise detection

Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation

Improvement of lay rescuer chest compressions with a novel audiovisual feedback device: A randomized trial

EFFECT OF DIFFERENT CUT POINTS FOR DEFINING SUCCESS POST-CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION - A SUB-STUDY OF THE STAR AF II TRIAL

International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug‐induced torsades de pointes

Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome

Atypical antipsychotics: From potassium channels to torsade de pointes and sudden death

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3

Magnetic resonance imaging and implantable cardiac devices. Current status and future perspectives of MR-compatible systems

Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options

Klinische Besonderheiten der Therapie mit Amiodaron

Suchergebnisse filtern